scarl

13% down on XBI, 40% upside on LabD

Short
AMEX:XBI   SPDR Series Trust SPDR S&P Biotech ETF
Nice double top, retrace to the bottom of the channel, potential full breakdown depending on the broader market over the next month.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.